The immune inhibitory receptor VISTA as regulator of stemness in acute myeloid leukemia
University of Bern
Department of BioMedical Research (MEM) E808
Murtenstrasse 35
3008 Bern
Prof. PhD Carsten Riether
CHF 200’00.00
Targeting dysregulated inflammasome activation in Myeloid Malignancies
Universitätsklinik für Hämatologie Inselspital/Universitätsspital
Department for BioMedical Research, University of Bern
Murtenstrasse 40,
3000 Bern
PD. Dr. Ramanjaneyulu Allam
CHF 197'463.00
Genome-Wide CRISPR-Knockout Screen for Identification of Immunomodulatory Genes in Glioblastoma
Department of Neurology, University Hospital Zurich
Frauenklinikstrasse 26,
8091 Zürich
Prof. Dr. med. Michael Weller
CHF 175’000.00
Studying neutrophils as mediators of synthetic lethality, sensitizing breast cancer to immunotherapy
IOR Institute of Oncology Research
Via Francesco Chiesa 5
6500 Bellinzona
Prof. PhD Arianna Calcinotto
CHF 250’000.00
Role of LCMT1 in T Cell Exhaustion and Cancer Immunotherapy
Department for Biomedicine ZLF
Universitätsspital Basel
Hebelstrasse 20
4031 Basel
Dr. med. Dominic Schmid, MD-PhD student in Experimental Biomedicine | 09/2019 - present
CHF 245’380.00
Loss of cell-cycle checkpoints in order to maximize low-dose radiation-induced inflammatory responses and sensitize ovarian cancer to immune checkpoint blockade therapy
Chemin de la Fauvette 61, 1012 Lausanne
MD, PhD Fernanda Herrera
CHF 190'000.00
Precision Oncology Targeting of Folic Acid Metabolism in Pediatric Osteosarcoma
University Children's Hospital Zürich, Steinwiesstrasse 75, 8032 Zürich
Dr. med. Univ. et Dr. phil Raphael Johannes Jonathan Morscher
CHF 241’738.00
Mitochondrial reprogramming to restore age-driven dysfunction in T cell and boost
CAR-T cell therapy
Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne, Biopole 3 Chemin des Boveresses 155, 1066 Epalinges
PhD Nicola Vannini Group Leader
CHF 135’808.00
Characterization and optimization of small molecules able to restore PTEN physiological levels and/or activity in prostate cancer
Head Computational Structural Biology, Institute for Research in Biomedicine, Via
Vincenzo Vela 6, 6500 Bellinzona
Dr. Andrea Cavalli, PhD
CHF 160'600.00
TAXIS — Tailored Axillary Surgery
Brustchirurgie, Universitätsspital Basel, Spitalstrasse 21, 4031 Basel
Prof. Dr. Walter Weber
CHF 126'870.00
Transcriptional regulation of T cell lymphoma development
Institute for Research in Biomedicine, Via Vincenzo Vela 6, 6500 Bellinzona
PhD Silvia Monticelli
CHF 153'000.00
Advancing cancer immunotherapy with non-viral engineering of multifunctional CAR T cells
Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Ramistrasse 100, 8091 Zurich
PhD Assisant Professor Chiara Francesca Magnani
CHF 210'000.00
Mechanisms of cancer resistance to CAR-T cell therapy
Istituto di Ricerca in Biomedicina, Via Vincenzo Vela 6, 6500 Bellinzona
Prof. Dr. Roger Geiger
CHF 190'000.00
Use of lymphoma ex-vivo biopsies as a platform to anticipate individual response to therapies
Swiss Institute for Experimental Cancer Research EPFL, 1015 Lausanne
PhD, Associate Professor Elisa Oricchio
CHF 177’000.00
Differential role of IL-33 in colorectal cancer development
Institute of Pathology, University of Bern, Murtenstrasse 31, 3008 Bern
PD (Dr. Sc. Nat. ETHZ), Prof. Philippe Krebs
CHF 170’000.00
MET as a target for combined modality treatment of glioblastoma
Chairman University Hospital Zurich, Department of Neurology
Frauenklinikstrasse 26,
8091 Zurigo (Svizzera)
Prof. Dr. Michael Weller
CHF 250'000.00
Impact of the tyrosine kinase inihibitor disatinib on lymphoid tissue microenvironment and tumor cell niche
Dept. OMI, University of Fribourg
Ch. du Musee 5,
1700 Friborgo (Svizzera)
Prof. Jens V. Stein
CHF 187'289.00
Identifying the mode of action of the anti-tumor immune response induced by selected Clostridiales bacteria in colorectal cancer patients
Leiter Forschung, Leiter Translationales Mikrobiom Forschungszentrum
Universitatsspital Zurich, Klinik fur Gastroenterologie and Hepatologie
Ramistrasse 100,
8091 Zurigo (Svizzera)
Prof. Dr. med. Michael Scharl
CHF 168'291.00
PREDICT — Peptide Radiotracers Enabling high-contrast PD-1 targeted Diagnostic Imaging of antigen-experienced T-cells for improved prediction of response to Immune Checkpoint targeted Therapies
Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Molecular Imaging, CHUV, Department of Oncology,
UNIL, Centre Hospitalier Universitaire Vaudois (CHUV)
Agora, B25A/03/094
Rue du Bugnon 25A,
1011 Lausanna (Svizzera)
Prof. Dr. Margret Schottelius
CHF 216'000.00
Immunotherapy of breast carcinoma through combination of PLGA-microsphere based vaccination with immune checkpoint blockade
Biotechnology Institute Thurgau Unterseestrasse 47
8280 Kreuzlingen (Svizzera)
Prof.Dr. Marcus Groettrup
CHF 140'000.00
“Helping the Killers”: innovative cancer immunotherapy harnessing “quasi-universal” tumor-specific CD4 T cells
Targeting of Cytokine secreting lymphocyte (TCSL) group
Department of Oncology UNIL-CHUV and Ludwig Institute for Cancer Research Biopole III, Chemin des Boveresses 155
1066 Epalinges (Svizzera)
MD, Ph.D. Camilla Jandus-Marone SNSF Assistant Professor,
CHF 150’000.00
Analysis of the tumor immune signature and effect of immunotherapy in a mouse model of small cell lung cancer.
Ecole Polytechnique Federale de Lausanne, Station 19, 1015 Lausanne (Svizzera)
Etienne Meylan, PhD
CHF 70'000.00
Extracellular ATP as target in tumor environment to improve adaptive immunity.
Istituto di Ricerca in Biomedicina (IRB), Via Vela 6, 6500 Bellinzona (Svizzera)
Fabio Grassi, MD, PhD
CHF 162'000.00
Examination of the tumor environment to boost immunotherapy in pancreatic cancer.
Experimental Pathology, University of Bern, 3000 Bern (Svizzera)
Mirjam Schenk, PhD
CHF 143'000.00
Targeting chemoresistance and tumor microenvironment in colon cancer.
Division of Experimental Pathology, CHUV 1015 Lausanne (Svizzera)
Tatiana Petrova, PhD
CHF 87'000.00
A proof-of-concept, prospective, observational study to investigate the value of Liquid Biopsies to predict tumor response after neoadjuvant chemo-radiotherapy in patients with locally advanced Rectal Cancer: the LiBReCa study.
Istituto cantonale di patologia, 6600 Locarno (Svizzera)
Prof. Dr. med. Dimitri Christoforidis
CHF 158’000.00
The ethical communication of medical diagnosis and prognosis: a certificate of advanced studies (CAS) through Medical Humanities.
Fondazione Sasso Corbaro, 6500 Bellinzona (Svizzera)
Prof. Dr. med. Roberto Malacrida
CHF 10’000.00
Uncovering the T cell-intrinsic role of NLRC5 in antitumoral responses.
Department of Biochemistry, University of Lausanne, Chemin des Boveresses 155, 1066 Epalinges (Svizzera)
Greta Guarda, PhD,
CHF 153’140.00
TCR activation is compromised in CD8 T cells transduced with a Chimeric Antigen Receptor (CAR). Implications for CAR-T cell mediated immunotherapy.
Departement of Fundamental Oncology and Ludwig Center for Cancer
Research- Biopole 3, Ch.des Boveresses 155, 1066 Epalinges
(Svizzera)
Alena Donda PhD
CHF 65’000.00
Intravital study of the traffcking of B lymphoma cells in the lymphatic compartment.
IRB, Institute for Research in Biomedicine, Via Vela 6, 6500 Bellinzona (Svizzera)
Fernandez Gonzales Santiago PhD, PhD.
CHF 200’000.00
Understanding and targeting chemoresistance in colorectal cancer.
University of Lausanne and CHUV, Ch. Des Boveresses 155, 1066 Epalinges (Svizzera)
Tatiana Petrova PhD.
CHF 70’000.00
Modulation of colorectal cancer immune contexture by gut microbiota.
Universitätsspital Basel, Zentrum für Lehre und Forschung (ZLF),
Hebelstrasse 20, 4031 Basel (Svizzera)
Giandomenica Iezzi, PD Dr. med.
CHF 120'000.00
Dissecting the association of the human palatine tonsil microbiome and HPV-driven oropharyngeal squamous cell carcinoma
Institut für Immunbiologie
Rorschacher Strasse 95, Kantonspital St.Gallen (Svizzera)
Prof. Dr. Ludewig Burkhard
CHF 144’000.00
Novel Active Combinations Containing Bromodomain (BRD) and Extra-terminal (BET) Inhibitors for Patients with Germinal Center B-cell Type
Diffuse large B-cell lymphoma
Institute of Oncology Research, Via Vela 6, 6500 Bellinzona (Svizzera)
Eugenio Gaudio PhD
CHF 160’000.00
Role of BCL2 genetic heteroclonality in the pathogenesis of B-cell lymphomas with BCL2 rearrangement
Istituto Cantonale di Patologia, Via in Selva 24, 6600 Locarno (Svizzera)
Prof. Dr. Med. Luca Mazzucchelli
CHF 170’000.00
Oncogenic aversion: A concept towards new therapeutic avenues in prostate cancer
Institute of Oncology Research, Via Vela 6, 6500 Bellinzona (Svizzera)
Prof. Dr. med. Jean-Philippe Theurillat
CHF 170’000.00
Role of Notch signaling and therapeutic potential of exosomes in
cardiomyopathy induced by doxorubicin & trastuzumab cancer treatment
Cardiocentro Ticino, Via Tesserete 48, 6900 Lugano (Svizzera)
Prof. Dr. med. Giuseppe Vassalli
CHF 120'000.00
Dissecting critical cellular and molecular mechanisms of acute erythroleukemia
University of Basel, Department of Biomedicine, ZLF, Childhood leukemia
group, Hebelstrasse 20, 4031 Basel, (Svizzera)
Prof. Dr. med. Jürg Schwaller
CHF 120'000.00
Role of IL-33/ST2 signaling in intestinal tumorigenesis
Institute of Pathology, P.O. Box 62, Murtenstrasse 31, 3010 (Svizzera)
Philippe Krebs, PhD
CHF 120’000.00
Co-targeting angiogenesis and immunosuppression to improve cancer therapy
ISREC-EPFL SV, Batiment SV, Station 19-Room SV2527, 1015 Lausanne (Svizzera)
Dr. med . Michele De Palma
CHF 138’000.00.
Dissecting the role of autophagy in normal and malignant B cells towards a rational novel therapeutic target in malignant B cell lymphomas
Inselspital, Universitätsklinik für Medizinische Onkologie, 3010 Bern (Svizzera)
Dr. Urban Nowak
CHF 70’000.00.
A single-arm, phase II trial evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsiv breast cancer who desire pregnancy. Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer (POSITIVE)
University of Bern, Departement of Medical Oncology, Murtenstrasse 35,
3010 Bern (Svizzera)
Dr.ssa Manuela Rabaglio
CHF 216'000.00.
Innate Lympoid Cells (ILCs). A novel effector cell in human cancer
University of Lausanne, Ludwig Center for Cancer Research, Av. Pierre Decker 4,
1005 Lausanne (Svizzera)
Dr.ssa Camilla Jandus-Marone,
CHF 169'000.00.
Inhibition of CD27 and BCR/ABL signaling in leukemia stem cells
Institute for Medical Oncology, Inselspital University Hospital 3010 Bern (Svizzera)
Prof. Dr. med. Adrian Ochsenbein
CHF 110’670.00.
Identification of novel genetic and epigenetic determinants for oncogenic
transformation in patients with systemic mastocytosis
Institute for Research in Biomedicine, Via Vincenzo Vela 6, 6500 Bellinzona
(Svizzera)
Silvia Monticelli, PhD
CHF 129’740.00.
Identification of novel targets in central nervous systeminfiltration in acute T lymphoblastic leukaemia
Institutefor Research in Biomedicine (IRB), 6500 Bellinzona (Svizzera)
Fabio Grassi MD PhD
CHF150’000.00.
The role of MYC in cancer cell invasion and metastasis
Centrepluridisciplinaire d'Oncologie, Rue du Bugnon 46, 1011 Lausanne (Svizzera)
Anita Wolfer MD PhD
CHF 150'000.00.
Mechanism of small cell lung cancer
Divisionof Experimental Oncology, CePO, CHUV and University of Lausanne, Chemin deBoveresses 155, 1066 Epalinges(Svizzera)
Tatiana Petrova PhD
CHF120'000.00.
Exploring the role of Toll-interacting protein in colitis-associatedcolorectal cancer development
CHUV,BH10-535, Rue du Bugnon 46, 1011 Lausanne (Svizzera)
Dr. Michel Maillard
CHF120’000.00.
Therole of calretinin in asbestos-induced malignant mesothelioma investigated inthe NF2+/- mouse model
Unitof Anatomy, Dept. Of Medicine, University of Fribourg, Route AlbertGockel 1 1700 Fribourg (Svizzera)
Prof. Beat Schwaller
CHF85’000.00.
Functional characterization of an 11q24.3 gain contributing to the pathogenesis of diffuse large B cell lymphoma by blocking B-cell maturation Istituto Oncologico di Ricerca, Via Vela 6, 6500 Bellinzona (Svizzera)
Prof. Dr. med. Francesco Bertoni
CHF 231’000.00.
The role of chemokine synergy-inducing molecules in controlling the tumor microenvironment, cell migration and metastasis
Institute for Research in Biomedicine, Via Vela 6, 6500 Bellinzona (Svizzera)
Dr.ssa Mariagrazia Uguccioni
CHF 173’000.00.
PI3K isoforms in Melanoma Formation and Progression
Institute Biochemistry & Genetics, Departement of Biomedicine, Mattenstrasse 28, Basilea, (Svizzera).
PhD Romina Marone
CHF 45'200.00
Functional characterization of endoplasmic reticulum-associated protein degradation regulators implicated in tumor progression.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona, (Svizzera).
PhD Maurizio Molinari
CHF 190'000.00
Analisi delle proteine che interagiscono col recettore CXCR4 in diversi tessuti. Progetto CXCR4, richiesta di estensione.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona, (Svizzera).
PhD Tiziana Apuzzo
CHF 40'000.00
Exploring tumor-specific genes as potential novel drug targets in colon cancer.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Dr. med. Pascale Anderle
CHF 59’000.00
Translational research workshop on gastroinstestinal tumors
ESMO (European Society for Medical Oncology), Lugano-Viganello,(Svizzera).
CHF 50’000.00
Ottimizzazione delle terapie endocrine per un trattamento individualizzato del cancro al seno: identificazione di nuovi parametri in seno allo studio TEXT del IBCSG, International Breast Cancer Study Group.
IOSI, Istituto Oncologico della Svizzera Italiana, Lugano-Viganello, (Svizzera).
Dr. med. Olivia Pagani
CHF 280'000.00
Identification of prognostic abnormalities in B-cell chronic lymphocytic leukaemia.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Dr. med. Francesco Bertoni
CHF 342’000.00
Kinase (P13K) in cancer-role for lipid compartmentalizazion.
Institute Biochemistry & Genetics
Departement of Biomedicine, Phosphoinositide 3, Basilea, (Svizzera).
Prof. Matthias P. Wymann PhD
CHF 40’000.00
Squamous cell anal cancer, chemoradiation, resistance predicitive molecular markers, immunohistochemistry, florescent in situ hybridizazion genemutations.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
Dr. med. Milo Frattini
CHF 110'000.00
Analisi delle proteine che interagiscono col recettore CXCR4 in diversi tessuti.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona, (Svizzera).
PhD Tiziana Apuzzo
CHF 36'776.00
British Columbia Cancer Agency, Vancouver, (Canada).
Dr. med. Alden Moccia
CHF 124'000.00
Piattaforma comunicativa sul sistema del cancro allestita dalla Fondazione Oncologia Lago Maggiore, Locarno, (Svizzera) in collaborazione con l’Institute of Communication and Health dell’USI, Università della Svizzera Italiana, Lugano, (Svizzera).
Dr. med. Augusto Pedrazzini
CHF 223'900.00
Cell super-competition and the discovery of novel markers and targets for detection and/or treatment of early stages of cancer.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
MD PhD Davide Soldini
CHF 29'600.00
Apertura di una Unità di microdissezione laser.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Dr. med. Carlo Catapano
Dr. med. Pascale Anderle Pedone
CHF 295'000.00
Premio 2005 Fondazione San Salvatore, per ricercatori esordienti.
Dr. med. Mifiana Urosevic, Zurigo, (Svizzera).
CHF 30'000.00
B2-adrenergic receptor influence in dendritic cell-based cancer vaccines.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
Dr. med. Georges Jean-Marie Maestroni
CHF 106'900.00
Cellular function of HsPi of HsPI 3-Kinase-C2a assessment of its role in transcription, centrsome integrity and cell cycle regulation.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona, (Svizzera).
Prof. Marcus Thelen
CHF 176’958.00
Molecular and biological mechanisms of non-Hodgkin’s lymphoma growth at extranodal sites.
IRB, Istituto di Ricerca in Biomedicina, Bellinzona, (Svizzera).
Dr. med. Mariagrazia Uguccioni
CHF 127’420.00
Studi di citogenetica avvalendosi della tecnica di FISH.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
PhD Dr. med . Luca Mazzucchelli
CHF 108'000.00
Role of Akt/PKB and pericytes in protecting endothelial cells against tumor Necrosis Factor-induced apoptosis.
Centre Pluridisciplinaire d’Oncologie, Faculté de Médicine, Université de Lausanne, Epalinges, (Svizzera).
Dr. med. Curzio Rüegg
CHF 137’252.00
Premio 2002 Fondazione San Salvatore, per ricercatori esordienti.
Departement of Experimental Haematology, Queen Mary’s Scool of Medicine and Dentistry, London e
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Dr. med. Francesco Bertoni
CHF 30’000.00
Hospice Ticino, Lugano, (Svizzera).
Sviluppo e presenza medica nell’ area del Sopraceneri
CHF 102’000.00
Molecular characterization of chromosome 11q in primary extranodal diffuse large B-celle lymphomas.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Dr. med. Francesco Bertoni
CHF 180'000.00
“Pilot study: Breast cancer data base (Carma)”.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Prof. Dr. med. Aron Goldhirsch,
Dr. med. Olivia Pagani,
Dr. med. Rossella Graffeo,
Prof. Dr. med. Jacques Bernier
CHF 130'000.00
Ricerca nel campo dell’immunologia oncologica allo Sloan Kettering
Cancer Center, New York, (USA).
Dr. med. Camilla Marone
CHF 10'000.00
Premio 2001 Fondazione San Salvatore, per ricercatori esordienti.
Anatomisches Institut der Universität, Berna, (Svizzera).
Dr. med. Valentin Djonov
CHF 30'000.00
Premio 2000 Fondazione San Salvatore, per ricercatori esordienti.
Dr. med. A.F. Ochsenbein,
Institut für Medizinische Onkologie Inselspital, Berna, (Svizzera).
CHF 20'000.00
PhD Dr. med. Luca Mazzucchelli,
Pathologisches Institut, Berna, (Svizzera).
CHF 20'000.00
Chemokine axpression and functions in Hodgkin’s disease.
Pathologisches Institut, Universität Bern, Berna (Svizzera).
PhD Dr. med. Luca Mazzucchelli
CHF 100’000.00
Analsys of the immunoglobulin heavy chain variable region in nodal marginal zone B-cell lymphoma and lymphoplasmacytoid lymphoma.
IOSI, Istituto Oncologico della Svizzera Italiana, Bellinzona, (Svizzera).
Dr. med. Emanuele Zucca
CHF 25’000.00
Neural influence on dendritic cell generation and function.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
Dr. med. Georges Jean-Marie Maestroni
CHF 25’000.00
Registro di donatori non apparentati di midollo.
Servizio Trasfusioni della Svizzera Italiana, Lugano, (Svizzera).
Dr. med. Damiano Castelli
CHF 80'000.00
Premio 1999 Fondazione San Salvatore per ricercatori esordienti.
Dr. med. Uwe Zangemeister-Wittke
Abt. für Onkologie, Universitätspital Zürich, Zurigo (Svizzera).
CHF 30'000.00
Effect of iNOS Expression on PhlP (a colon carcinogen) induced apoptosis and mutagenicity
Institut de Pharmacologie et Toxicologie, Losanna (Svizzera).
Dr. med. Phaik Morgenthaler Leong
CHF 60'000.00
Evaluating extranodal stage I and II low-grade lymphomas of the PMH.
Princess Margaret Hospital,
Department of Radiation Oncology, University of Toronto, (Canada).
Dr. med. Thomas Lippuner
CHF 30'000.00
Messa a punto dell’analisi BRCA1 e BRCA2 in Ticino.
Laboratorio Bioanalitico SA, Savosa, (Svizzera).
Dr. med. Alberto Pedrazzini
Dr. med. Gianbattista Soldati
CHF 60'000.00
The mitogenic action of phosphoinositide 3-kinases.
Istituto di Biochimica dell’Università di Friburgo, (Svizzera).
Dr. med. Matthias Paul Wymann
CHF 40'000.00
Transfert du gene Ku 32 pour augmenter la radiosensibilité de cellules de hamster et des cellules tumorales humains.
Ospedale San Giovanni, Bellinzona, (Svizzera).
PhD Dr. med, J. Bernier,
Dr. med. J. Bourhis,
Dr. med. Ch. Badie,
CHF 72’233.00
Investigation of the clinical relevance of a novel subunit of the 26S proteasome which confers resistance to antitumour drugs in vistro and is variably expressed in tumour cell lines.
Servizio Oncologico cantonale, Bellinzona, (Svizzera).
Dr. med. Vito Spataro
CHF 24’000.00
Pathological role of cathepsin B in osteoarhriris splicing of mRNA.
Zentrum für Experimentelle Rheumatologie,
Universität Zürich, Zurigo (Svizzera).
Prof. Dr. med. Antonio Baici
CHF 89'000.00
Premio 1998 Fondazione San Salvatore per ricercatori esordienti.
Dermatologische Klinik Universitätsspital Zürich, Zurigo (Svizzera).
Dr. med. Reihnard Georg Dummer
CHF 30’000.00
Registro Svizzero dei Donatori di Midollo, Berna, (Svizzera).
CHF 50'000.00
Phage display libraries for the identification of cell-targeting peptides for growth and activation receptors.
Brigham and Women’s Hospital, Department of Pathology, Boston, (USA).
PhD Dr. med . Luca Mazzucchelli
CHF 45'000.00
Characterization and distribution of alpha-1 adrenoceptors in human hematopoietic cells: a basis for new therapeutic strategies in oncology?.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
Dr. med. Georges Jean -Marie Maestroni
CHF 100'000.00
Study of sterol-regulated proteolytic processing of sterol regulatory element binding protein (SREBP) in vivo.
Southwestern Medical Center, Department molecular Genetic, University of Texas, Dallas, (USA).
Dr. med. Luca Barella
CHF 25’000.00
Gastric MALT lymphoma as a model of tumour progression: evolution from Helicobacter pylori gastritis to low-grade and high-grade lymphomas.
Servizio Oncologico Cantonale, Bellinzona, (Svizzera).
Dr. med. Emanuele Zucca
CHF 150’000.00
Registro Svizzero dei Donatori di Midollo, Berna, (Svizzera).
CHF 50'000.00
Angiogenesi, neovascolarizzazione del tumore. Identificazione dell’ inibitore per arrestare la crescita in vivo.
Laboratory of tumor Biology and Genetics, Neurosurgery Service, CHUV, Losanna, (Svizzera).
Dr. med. Erwin G. Van Meir
CHF 82'000.00
Analyse du récepteur pour l’antigène des lymphocytes en cas de maladie greffon contre l’hôte après allogreffe osseuse HLA compatible : une étape vers la caractérisation des antigènes mineurs d’ histocompatibilité. Ospedale Cantonale di Ginevra, Ginevra, (Svizzera).
Dr. med. Pierre Yves Dietrich
CHF 136'260.00
Corso di perfezionamento di terapia radiante in Francia.
Clinica di radioterapia Gustave-Roussy, Villejuif, (Francia).
Dr. med. Susanne Diener
CHF 40'000.00
Interphase cytogenetic Analysis by fluorescent non radioactive in-situ
Hybridization (metodo FISCH) in the diagnosis and study of centrocytic lymphoma.
Ospedale San Giovanni Fondo Oncologico Ticinese ”OSG” Trapianti, Bellinzona, (Svizzera).
CHF 50'000.00
Corso di perfezionamento in cure palliative a Edmonton,(Canada).
Dr. med. Hans Neuenschwander
CHF 30'000.00
Soggiorno di due anni presso il “New York Blood Center” New York ed il “Departement of Laboratory Medicine” della Georgetown University Medical Center a Washington (USA)
Dr. med. Beat M. Frey
CHF 100'000.00
Esperimenti con cellule modificate geneticamente, per la produzione di varie citochine presso il laboratorio del Prof. Dr. J.A. Norton, St. Louis, (USA)
Gene-transfer-program
Dr. med. A. Oertli
CHF 40'000.00
Niveau d’information à propos de la maladie et du traitement, dépréssion et anxiété chez les patients cancéreux,
Université de Genève, Ginevra (Svizzera).
Dr. med. Marc Archinard
Dr. med. André Haynal
CHF 152'309.00
Istituto di Patologia di Locarno (Svizzera).
Dr. med. Ennio Pedrinis
CHF 20'286.00
ATP-Assay, Adenosintriphosphat. Test sulla sensibilità di tumori ginecologici e mammari alle applicazioni chemoterapeutiche.
Universitätsfrauenklinik Zürich, Zurigo (Svizzera).
Prof. Dr. med. Urs Haller
Dr. med. Ossi R. Koechli
CHF 143’646.00
Gruppo di Lavoro Interdisciplinare ”Senologia Cliniche Luganesi”, Lugano (Svizzera).
Dr. med. Marco Varini
CHF 50'000.00
In vitro assay of intrinsic radioresistance as predictive test of radiocurability
Ospedale San Giovanni, Bellinzona (Svizzera)
Ospedale Civico, Lugano (Svizzera)
Ospedale Beata Vergine, Mendrisio (Svizzera)
Ospedale La Carità, Locarno (Svizzera)
Centre Hospitalier Universitaire Vaudois, Losanna (Svizzera)
CHF 465’000.00
Krebsatlas der Schweiz (Zürich/Basel).
Schweizerische Krebsliga, Berna, (Svizzera).
Dr. med. G. Schüler
Dr. med. M. Bopp
CHF 10’000.00
Tumor Infiltrating Lymphocytes.
Adt Forschung des Dept.Chirurgie,
Universität, Basilea, (Svizzera).
PhD Dr. med. Michael Heberer
CHF 260’000.00
The Role of pineal gland immunity.
Istituto Cantonale di Patologia, Locarno, (Svizzera).
Dr. med. Georges Jean-Marie Maestroni
Dr. med. Ario Conti
CHF 20'000.00
Evolution Psychologique des patients cancéreux.
Unité de medicine psychosomatique et psychosociale,
Université de Genève, Ginevra (Svizzera).
Dr. med. Marc Archinard
Prof. Dr. med. André Haynal
CHF 140'000.00
Ricostituzione immunologica dopo chemioterapia.
Ospedale La Carità, Servizio Oncologico, Locarno, (Svizzera).
Dr. med. Augusto Pedrazzini
CHF 100'000.00
Schweizerische Krebsliga
Kisk Kommission der Krebsliga über Iionisierende Strahlen und Krebs, Berna, (Svizzera).
CHF. 100’000.00